等待开盘 11-19 09:30:00 美东时间
-0.061
-0.24%
TAMPA, Fla., Nov. 12, 2025 /PRNewswire/ -- Crown Holdings, Inc. (NYSE: CCK) ("Crown") today announced that its wholly-owned subsidiary Crown Cork & Seal Company, Inc. (the "Company") has com...
11-12 21:00
Adverum's lead program, Ixo-vec, is a Phase 3 gene therapy designed to treat vision loss associated with wet age-related macular degeneration with a single intravitreal dose Acquisition ali...
10-24 20:30